BioQ Pharma to Present at the 15th Annual Needham Healthcare Conference

SAN FRANCISCO, April 05, 2016 -- BioQ Pharma, a specialty pharmaceutical company focused on the development and commercialization of large volume ready-to-use infusible pharmaceuticals, announced today that the Company will be presenting at the 15th Annual Needham Healthcare Conference to be held in New York City on April 12th and 13th, 2016.

Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Wednesday, April 13th at 8:40 a.m. Eastern Daylight Time.

About BioQ Pharma

BioQ Pharma is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharm, Lunatus, and West Pharmaceutical Services.

Company Contact Information:

Josh Kriesel
President and CEO
415-336-6496

Ron Pauli
Chief Financial Officer
415-889-7707

Media:
Stephanie Carrington
Integrated Corporate Relations, Inc (ICR)
646-277-1282